The U.S. Department of Justice filed a brief on March 13, 2017, arguing the potential merger between Bloomfield, Conn.-based Cigna and Indianapolis-based Anthem would result in increased prices to consumers and hampered innovation in the market, the CT Mirror reports.
Here's what you should know.
1. Cigna appealed a federal judge's ruling against its potential merger with Anthem.
2. The DOJ's brief reaffirms its position from the antitrust trial that the merger would hamper U.S. markets.
3. Anthem presented a plan showing the merger's impact on medical costs. The DOJ said the projected savings from Anthem's medical cost savings plan are "purely aspirational and cannot justify the proposed merger."